Cancer Research UK is working with global biopharma Sosei Heptares on a treatment they hope will bring immunotherapy benefits to new cancer types. Jonah Comstock delves into what makes this team ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

PROVIDENCE, R.I., Jan. 29, 2025 /PRNewswire/ -- The Rhode Island Neuroscience Symposium gathered 300 researchers, clinicians, industry leaders and entrepreneurs yesterday to showcase the region's ...

The symposium opened with a keynote address by Brad Margus, a biotech entrepreneur, innovator and advocate for neurodegenerative disease research and co-founder of Cerevance and Board Chair of ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

CVN-293 is under clinical development by Cerevance and currently in Phase I for Alzheimer’s Disease. According to GlobalData, Phase I drugs for Alzheimer’s Disease have a 63% phase transition success ...

CVN-293 is under clinical development by Cerevance and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData, Phase I drugs for Amyotrophic Lateral Sclerosis have an 81% ...